LenzaGel description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

LenzaGel

Pharmaceutica North America, Inc.

LenzaGel


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

LenzaGel


Active Ingredients:

Lidocaine HCL 4.00%

Menthol 1.00%


Purpose

Topical Analgesic

External Analgesic

Uses:

For temporary relief of pain associated with minor cuts, scrapes and minor skin irritations.

Warnings

  • For external use only
  • Avoid contact with eyes
  • Do not apply to open wounds or damaged skin.
  • If symptoms persist for more than seven days, discontinue use and consult physician.

Keep out of reach of children.

If swallowed, consult physician.


  • Do not bandage tightly
  • If pregnant or breast feeding, contact physician prior to use.
  • Do not use in large quantities, particularly over raw surfaces or blistered areas.

Directions

  • Apply directly to effected area. Do not use more than four times per day.

Other Ingredients:

Aloe Barbadensis Leaf (Aloe Vera Juice) Gel, Aqua (Deionized Water), Arnica Montana Extract, Boswellia Serrata Extract, Camellia Sinensis Leaf (Green Tea) Extract, Carbomer, Ethylhexylglycerin, Glycerin, Isopropyl Myristate, PEG-8, Phenoxyethanol, Polysorbate-80, Sodium Lauryl Sulfate, Triethanolamine, FD C Blue 1, FD C Yellow 5.

LenzaGel 120g (45861-016-01)

LenzaGel

LenzaGel

LIDOCAINE HYDROCHLORIDE, MENTHOL GEL

Product Information

Product Type Human otc drug label Item Code (Source) NDC:45861-016
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
LIDOCAINE HYDROCHLORIDE LIDOCAINE 4 g
MENTHOL 1 g

Inactive Ingredients

Ingredient Name Strength
Aloe Vera Leaf
water
ARNICA MONTANA
INDIAN FRANKINCENSE
GREEN TEA LEAF
ETHYLHEXYLGLYCERIN
GLYCERIN
ISOPROPYL MYRISTATE
polyethylene glycol 400
PHENOXYETHANOL
polysorbate 80
SODIUM LAURYL SULFATE
TROLAMINE
FD&C BLUE NO. 1
FD&C YELLOW NO. 5

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:45861-016-01 120 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part348 2013-03-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.